Figure 1.

Forest plots of adjusted odds ratio for seropositivity by BMI as a categorical variable with normal BMI (18.5–<25) as reference. (A) Includes participants with BMI measures and demonstrates a non-significant trend to declining seroprevalence with BMI ≥40 kg/m² when compared to normal/healthy weight (BMI 18.5–24 kg/m²) (n = 4270). (B) Includes only participants from a single high seroprevalence (22.5%) location in South Texas, where the high force of infection may more clearly delineate infection risks (n = 629).